Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale See Remarks sold 1,311 shares at $13.33 ($17,476)
  6. 4 Open-market sale See Remarks sold 2,209 shares at an average $13.18 ($29,116)
  7. 4 Open-market sale Chief Operating Officer sold 1,559 shares at $13.33 ($20,781)
  8. 4 Open-market sale Chief Medical Officer sold 7,441 shares at $13.33 ($99,189)
  9. 4 Open-market sale See Remarks sold 7,318 shares at $13.33 ($97,549)
  10. 4 Open-market sale Chief Scientific Officer sold 1,416 shares at $13.33 ($18,875)
  11. 4 Open-market sale See Remarks sold 10,000 shares at $14.03 ($140,300)
  12. 4 Open-market sale See Remarks sold 30,150 shares at $11.57 ($348,836)
  13. 4 Open-market buy Director bought 934,581 shares at $10.70 ($10,000,017)
  14. 4 Open-market buy 10% owner bought 934,581 shares at $10.70 ($10,000,017)
  15. 4 Open-market sale See Remarks sold 312 shares at $10.87 ($3,391)
  16. 4 Open-market sale See Remarks sold 472 shares at $10.87 ($5,131)
  17. 4 Open-market sale Chief Operating Officer sold 751 shares at $10.87 ($8,163)
  18. 4 Open-market sale Chief Medical Officer sold 628 shares at $10.87 ($6,826)
  19. 4 Open-market sale See Remarks sold 3,322 shares at $10.87 ($36,110)
  20. 4 Open-market sale Chief Scientific Officer sold 680 shares at $10.87 ($7,392)

Page 13 of 19 · 365 filings